Pubblicazioni

Long-term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. The Italian Experience.

2017 - BLOOD

Giona, Fiorina; Santopietro, Michelina; Menna, Giuseppe; Micalizzi, Concetta; Caterina Putti, Maria; Santoro, Nicola; Ziino, Ottavio; Mura, Rosamaria; Ladogana, Saverio; Iaria, Grazia; Sau, Antonella; Burnelli, Roberta; Vacca, Nadia; Nardi, Margherita; Consarino, Caterina; Miulli, Eleonora; Moleti, MARIA LUISA; Petruzziello, Fara; Maria Orlando, Sonia; Biondi, Andrea; Locatelli, Franco; Saglio, Giuseppe; Robin, FoÃ .

Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab through Augmentation of Macrophage-Induced ADCP

2017 - BLOOD

Naicker, S; Rigalou, A; Mcellistrim, C; Natoni, A; Chiu, C; Sasser, K; Ryan, A; O'Dwyer, M

Targeting Siglec-7: A Novel Immunotherapeutic Approach to Potentiate the Cytotoxic Functions of Natural Killer Cells Against Multiple Myeloma

2017 - BLOOD

Daly, J; Duggan, T; Hu, Js; Natoni, A; Sarkar, S; Kirkham-McCarthy, L; Mcellistrim, C; Krawczyk, J; O'Dwyer, M